Advisory Services Network LLC Has $1.38 Million Position in UnitedHealth Group Inc (UNH)

Advisory Services Network LLC increased its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 69.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,237 shares of the healthcare conglomerate’s stock after purchasing an additional 2,547 shares during the period. Advisory Services Network LLC’s holdings in UnitedHealth Group were worth $1,375,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in the stock. Global Financial Private Capital LLC grew its stake in shares of UnitedHealth Group by 13.7% during the fourth quarter. Global Financial Private Capital LLC now owns 18,386 shares of the healthcare conglomerate’s stock worth $4,053,000 after purchasing an additional 2,212 shares during the period. Toronto Dominion Bank grew its stake in UnitedHealth Group by 12.6% in the fourth quarter. Toronto Dominion Bank now owns 432,508 shares of the healthcare conglomerate’s stock valued at $95,350,000 after acquiring an additional 48,565 shares during the period. DE Burlo Group Inc. grew its stake in UnitedHealth Group by 5.6% in the fourth quarter. DE Burlo Group Inc. now owns 59,600 shares of the healthcare conglomerate’s stock valued at $13,139,000 after acquiring an additional 3,150 shares during the period. Advisory Research Inc. grew its stake in UnitedHealth Group by 2.4% in the fourth quarter. Advisory Research Inc. now owns 120,195 shares of the healthcare conglomerate’s stock valued at $26,498,000 after acquiring an additional 2,854 shares during the period. Finally, Bailard Inc. grew its stake in UnitedHealth Group by 70.7% in the fourth quarter. Bailard Inc. now owns 34,366 shares of the healthcare conglomerate’s stock valued at $7,576,000 after acquiring an additional 14,238 shares during the period. 86.79% of the stock is owned by institutional investors and hedge funds.

How to Become a New Pot Stock Millionaire

In related news, Director Kenneth Irwin Shine sold 198 shares of the company’s stock in a transaction dated Friday, January 19th. The stock was sold at an average price of $242.55, for a total transaction of $48,024.90. Following the sale, the director now owns 1,790,567 shares in the company, valued at $434,302,025.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of the company’s stock in a transaction dated Monday, March 19th. The stock was sold at an average price of $224.36, for a total value of $2,243,600.00. Following the sale, the director now owns 1,771,257 shares in the company, valued at approximately $397,399,220.52. The disclosure for this sale can be found here. Insiders have sold 77,015 shares of company stock worth $17,879,199 in the last quarter. 0.89% of the stock is currently owned by corporate insiders.

A number of research analysts have issued reports on UNH shares. Deutsche Bank boosted their target price on UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Cantor Fitzgerald reissued a “buy” rating and issued a $235.00 target price on shares of UnitedHealth Group in a research note on Tuesday, January 16th. BMO Capital Markets boosted their target price on UnitedHealth Group from $14.50 to $275.00 and gave the company an “outperform” rating in a research note on Wednesday, January 17th. Credit Suisse Group boosted their target price on UnitedHealth Group from $252.00 to $260.00 and gave the company an “outperform” rating in a research note on Wednesday, January 17th. Finally, Barclays started coverage on UnitedHealth Group in a research note on Thursday, March 8th. They issued an “overweight” rating and a $265.00 target price for the company. Three investment analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $244.62.

Shares of UnitedHealth Group stock opened at $214.00 on Friday. The stock has a market capitalization of $207,079.89, a PE ratio of 21.25, a PEG ratio of 1.25 and a beta of 0.74. UnitedHealth Group Inc has a one year low of $162.74 and a one year high of $250.79. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.73 and a current ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. During the same period in the previous year, the company posted $2.11 earnings per share. The company’s quarterly revenue was up 9.5% compared to the same quarter last year. analysts predict that UnitedHealth Group Inc will post 12.51 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 20th. Investors of record on Friday, March 9th were issued a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, March 8th. This represents a $3.00 annualized dividend and a yield of 1.40%. UnitedHealth Group’s payout ratio is presently 29.79%.

TRADEMARK VIOLATION WARNING: This report was first published by WKRB News and is owned by of WKRB News. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The legal version of this report can be read at https://www.wkrb13.com/2018/04/01/advisory-services-network-llc-has-1-38-million-position-in-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply